8-Hydroxy-6-methyl-9,10-dioxo-9,10-dihydro-1-anthracenyl beta-D-glucopyranoside(CAS: 13241-28-6)

This compound falls under multiple regulatory frameworks including GHS for hazardous chemicals, REACH for registration, evaluation, authorization, and restriction of chemicals in the EU, and FDA/EPA for safety and environmental regulations. Manufacturers and users must comply with local and international regulations, including proper labeling, storage, and disposal practices.

There are several alternatives for synthesis, including isomers and analogs such as 8-hydroxy-9,10-dioxo-9,10-dihydro-1-anthracenyl beta-D-glucopyranoside and related anthracene derivatives, which can serve as viable substitutes depending on the specific application requirements.

The market trend for this compound is growing due to its applications in pharmaceuticals and biotechnology. Research is focusing on its potential as a bioactive compound, with increasing demand from academia and industry. Price trends are stable, with demand expected to rise as more applications are discovered.

Waste containing this compound should be collected and disposed of according to local regulations. Preferred methods include incineration or professional waste disposal services. Ensuring the waste is properly labeled and treated to prevent environmental contamination is crucial. Environmental protection measures such as containment during handling and disposal should be implemented to minimize risks.